Huge win for activists as court enjoins Toho HD’s "poison-pill" takeover defence

Takeover defences have experienced a resurgence in the face of rising shareholder activism. This decision is a warning to company management
James Halse, CFA

Senjin Capital

For the first time in Japan a Tokyo court has upheld an activist’s request for a (provisional) injunction against the implementation of a takeover defence measure that was approved by a vote of the target company’s shareholders.

This is a major win for 3D Investment Partners over the management of the company in which it has invested – Toho HD. Underperforming management teams in Japan often seek to use takeover defence measures to entrench themselves by preventing economically-minded shareholders from gaining too much voting influence and thus effecting managerial change.

The judgment was delivered by a court of first instance, and the company has stated it will appeal the decision. The decision was also somewhat limited by the particular facts of the case. Despite this, the judgment could be so important for the progress of activism and public to private transactions in Japan, that it is worthwhile discussing in detail.

“Poison pills” that enable companies to dilute an undesirable shareholder that is labelled an “abusive acquiror”, have been utilised in Japan since the early 2000’s. With a key event being the Supreme Court upholding Bulldog Sauce’s takeover defence over the objections of US activist fund manager (at the time) Steel Partners.

Bull-Dog Sauce is the leading condiment for Tonkatsu (breaded pork cutlet)
Bull-Dog Sauce is the leading condiment for Tonkatsu (breaded pork cutlet)

Pills fell out of favour in the 2010s, but have experienced a resurgence with the rise in shareholder activism over the last four to five years – with 10 adopted last year alone (per IR Japan).

Poison-pills are in decline thanks to the corporate governance reform, but "emergency" measures, typically adopted when management perceives an unfriendly shareholder buying up its stock, have been on the rise due to growing shareholder activism.
Poison-pills are in decline thanks to the corporate governance reform, but "emergency" measures, typically adopted when management perceives an unfriendly shareholder buying up its stock, have been on the rise due to growing shareholder activism.

The basic principle established in judicial decisions is that such defences should only be utilised to prevent damage to the interests of minority shareholders that could arise from a single acquiror building a large stake on market and gaining effective or actual control over a company, without a plan to enhance the value of the company, or with intent to transfer value from minorities to itself. This was a particular issue in Japan, because until this year there was no requirement to make a tender offer to all shareholders upon passing a threshold level of ownership, so long as the stake was acquired on market. However, defences were not allowed to be implemented simply to entrench existing management.

The change to the statutes this year, is that to acquire past the level of a 30% shareholding, the acquiror must make a tender offer to all shareholders. The law remains much more permissive than in other jurisdictions, because the tender offer does not have to be for the entire company – it can be for any amount the acquiror wishes to bid for. That said, the introduction of this change may have been influential on the judge in this case.

The other core principle that has developed, is that takeover defences, including emergency measures implemented outside the normal course of shareholder meetings, must be approved by a vote of the shareholders. Typically, this occurs at the AGM, but for emergency measures (where an acquiror has rapidly built a stake in between AGM’s), the company calls an extraordinary meeting to hold the shareholder vote. This ties in with the basic principle – who is better to assess whether damage to shareholders’ interests is likely than the shareholders?

A nice idea in theory. In practice, however, because of often large cross/allegiant shareholdings which are classed as independent of management despite always voting with management, coupled with relatively low retail shareholder turnout, such votes could be difficult for activists to win. The result of such votes was often not in the best interests of the economic value of the shareholders’ shares! Indeed, in relation to the matter under discussion, 3D lost the AGM vote narrowly, with 54.7% supporting the measure. Toho HD’s register appears to show allegiant shareholders controlling a little under 20% of the voting rights (per Factset).

The court decided in this case, that the takeover defence as proposed, based on the facts of the case, was designed to entrench management, as there was no risk of 3D becoming an abusive acquiror and gaining control. This was the case despite the favourable shareholder vote.

The facts were that 3D owned 20.84% (per Factset) of Toho HD’s outstanding shares (more of the voting rights due to 11.4% of outstanding held by Toho HD as non-voting treasury shares) but told the court (and the company) it did not plan to acquire more than 27% of the voting rights – well below the 30% threshold for making a tender offer to all shareholders. Toho HD’s defence measure would be effected if 3D raised its stake above 24% of the vote (it is typical for management to set the threshold slightly above the current holding). 

The court said (machine translated): 

 "at least in this case, it is not appropriate to conclude that the common interests of shareholders have been harmed by the acquisition of debtor shares by creditors, etc., based solely on a resolution of the shareholders' meeting." 

This was based on the reasoning that because the acquiror had promised not to acquire more than 27% of the voting rights, control was not involved. The company needed to show shareholder interests risked actual harm, it was not enough that shareholders approved the defence measures. For similar reasons, the acquisition was not "coercive" in nature

The company claimed 3D's requests and suggestions regarding its management harm the common interests of shareholders: The court said that 3D's proposals were quite: 

"ordinary proposals from institutional investors seeking to improve capital efficiency, and cannot be considered to be aimed at pursuing their own interests at the expense of the common interests of shareholders, nor can the other proposals themselves be said to be unreasonable."

While a great result for 3D, it remains to be seen whether the decision will have broader applicability. In particular, the key questions are:

  • 3D’s statement that it would not acquire more than 27% of the voting rights was clearly important to the Court, but is 27% now the magic number or will the courts look more at the new 30% (of outstanding, rather than voting) legislative threshold for requiring a tender offer to all shareholders?
  • Will the judgment be relevant to non-emergency measures that were in place before the acquiror entered the stock? Typically the implementation trigger threshold for these has been set at 20%, so this would be a huge change.

Depending on the answers to these questions, we could see a flood of similar applications to the court by activists. Recent cases of shareholder votes approving pills that were clearly against the best interest of shareholders include Aska Pharma, Bunka Shutter, and Ain Holdings. All these cases involve very well-funded activists. 

........
This material is for general information only and is not an offer for the purchase or sale of any financial product or service. The material has been prepared by Senjin Capital Pty Ltd and Senjin Asset Management Pty Ltd for investors who qualify as wholesale clients under sections 761G of the Corporations Act or to any other person who is not required to be given a regulated disclosure document under the Corporations Act. The material is not intended to provide you with financial or tax advice and does not take into account your objectives, financial situation or needs.  Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Senjin Capital, Senjin Asset Management, any of their related body corporates or any other person. To the maximum extent possible, 62C, Senjin, their related body corporates or any other person do not accept any liability for any statement in this material. Senjin Capital Pty Ltd (CAR #001314185) and Senjin Asset Management Pty Ltd (CAR #001314259) are both corporate authorised representatives of 62 Consulting Pty Ltd (AFS License 548573). This presentation does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein or offered in connection with this presentation have not been, and will not be, registered under the Securities Act. They may not be offered, sold, transferred, distributed or delivered, directly or indirectly within, into or in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No public offering of the securities will take place in the United States. Neither the US Securities and Exchange Commission nor any securities regulatory authority of any state or other jurisdiction of the United States has approved or disapproved of an investment in the securities or passed on the accuracy or adequacy of the contents of this presentation. Any representation to the contrary is a criminal offence in the United States. This presentation is directed at This presentation contains forward‐looking statements. These statements may include the words “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “project”, “will”, “may”, “targeting” and similar expressions as well as statements other than statements of historical facts including, without limitation, those regarding the financial position, business strategy, plans, targets and objectives of the management of the Company for future operations (including development plans and objectives). Such forward‐looking statements involve known and unknown risks, uncertainties and other important factors which may affect the Company's ability to implement and achieve the economic and monetary policies, budgetary plans, fiscal guidelines and other development benchmarks set out in such forward‐looking statements and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward‐looking statements. Such forward‐looking statements are based on numerous assumptions regarding the Company’s present and future policies and plans and the environment in which the Company will operate in the future. Furthermore, certain forward‐looking statements are based on assumptions or future events which may not prove to be accurate, and no reliance whatsoever should be placed on any forward-looking statements in this presentation. The forward‐looking statements in this presentation speak only as of the date of this presentation, and the Company expressly disclaims to the fullest extent permitted by law any obligation or undertaking to disseminate any updates or revisions to any forward‐looking statements contained herein to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. Nothing in the foregoing is intended to or shall exclude any liability for, or remedy in respect of, fraudulent misrepresentation. The information in this presentation has not been independently verified. No representation or warranty, express or implied, is made as to the fairness, accuracy or completeness of the presentation and the information contained herein and no reliance should be placed on it. Information in this presentation (including market data and statistical information) has been obtained from various sources (including third party sources) and the Company does not guarantee the accuracy or completeness of such information. All projections, valuations and statistical analyses are provided for information purposes only. They may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results and to the extent they are based on historical information, any they should not be relied upon as an accurate prediction of future performance. Any financial data in this presentation are solely for your information, as background to the Company and may not be relied upon for the purpose of entering into any transaction whatsoever. The financial information set out in this presentation is based on certain important assumptions and adjustments and does not purport to represent what our results of operations are on an audited basis or actually will be in any future periods. Furthermore, no representation is made as to the reasonableness of the assumptions made in this presentation or the accuracy or completeness of any modelling, scenario analysis or back‐testing. The information in this presentation is not intended to predict actual results and no assurances are given with respect thereto. None of the Company, its advisers, connected persons or any other person accepts any liability whatsoever for any loss howsoever arising, directly or indirectly, from this presentation or its contents. All information, opinions and estimates contained herein are given as of the date hereof and are subject to change without notice. Conflicts of interest. Senjin, and their respective related bodies corporate, directors, officers, employees and associates may hold, acquire or dispose of direct or indirect interests in securities, financial products, portfolio companies or other investments referred to in this material, including investments also held or considered by the Senjin Capital Fund I. They may also receive fees or other benefits in connection with those interests. These circumstances may give rise to actual, potential or perceived conflicts of interest. Relevant conflicts are managed in accordance with applicable law and the conflicts-management arrangements of Senjin.

James Halse, CFA
Managing Director & CIO
Senjin Capital

Jamie is the founder & CIO of Senjin Capital, Australia's only fund manager focused on using shareholder activism to unlock the deep value in Japanese publicly-listed small cap companies. Prior to founding Senjin in 2024, Jamie spent 13 years...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment